Association of free androgen index and sex hormone–binding globulin and left ventricular hypertrophy in postmenopausal hypertensive women
Authors:
Open Access
- 9 June 2021
- journal article
- research article
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 23 (7) , 1413-1419
Abstract
The aim of the present study was to explore the relationship between androgen and LVH in postmenopausal hypertensive women. Enrolled in this study were 378 postmenopausal hypertensive women who were admitted to the department of cardiology between December 2018 and December 2020. According to left ventricular mass index (LVMI) evaluated by echocardiography, the patients were divided into LVH group (n = 172) and non-LVH group (n = 206). Their clinical characteristics were collected. Based on the result of propensity score matching analysis, 160 cases in each group were matched successfully. After correcting for confounding factors by various models, the results showed that free androgen index (FAI) and sex hormone–binding globulin (SHBG) were the influencing factors of LVH in postmenopausal women with hypertension. Patients with elevated SHBG were 5% less likely to develop LVH than those without elevated SHBG (OR: 0.950, 95% CI 0.922-1.578). Postmenopausal hypertensive patients with elevated FAI were 16% more likely to have LVH than those without elevated FAI (OR: 1.608, 95% CI 0.807-3.202). Multiple linear regression showed that LVMI increased by 61.82g/m2 for every 1 unit increase in FAI. In addition, SHBG decreased by 1 nmol/l, and LVMI increased by 0.177g/m2. Subgroup analysis showed that patients in the controlled BP group had a lower risk of LVH for every additional unit of SHBG compared with the uncontrolled BP group. The risk of LVH for each additional unit of FAI in the uncontrolled BP group was higher than that in the controlled BP group. The results of this present study showed that the occurrence of LVH was positively correlated with FAI and negatively correlated with SHBG in postmenopausal women with hypertension. The increase in FAI level and the decrease in SHBG level may be related to the occurrence and development of LVH in postmenopausal hypertension.Keywords
Funding Information
- National Natural Science Foundation of China (81670385)
This publication has 29 references indexed in Scilit:
- Free androgen index as a predictor of blood pressure progression and accelerated vascular aging in menopauseAtherosclerosis, 2016
- Total testosterone levels are correlated to metabolic syndrome componentsThe Aging Male, 2016
- mTORC1 Phosphorylation Sites Encode Their Sensitivity to Starvation and RapamycinScience, 2013
- Testosterone Supplementation in Male Obese Zucker Rats Reduces Body Weight and Improves Insulin Sensitivity But Increases Blood PressureHypertension, 2012
- Inverse association between total testosterone concentrations, incident hypertension and blood pressureThe Aging Male, 2010
- MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in miceJournal of Clinical Investigation, 2010
- Testosterone induces cardiomyocyte hypertrophy through mammalian target of rapamycin complex 1 pathwayJournal of Endocrinology, 2009
- Sex-Based Cardiac PhysiologyAnnual Review of Physiology, 2009
- Androgen Contributes to Gender-Related Cardiac Hypertrophy and Fibrosis in Mice Lacking the Gene Encoding Guanylyl Cyclase-AEndocrinology, 2004
- Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findingsThe American Journal of Cardiology, 1986